Safety/Efficacy of Systane Free vs Refresh Tears
NCT00348322 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2008-09-25
Summary
The objective of this study is to evaluate the safety and efficacy of Systane Free FID 105783 in comparison to Refresh Tears Lubricant Eye Drops (Allergan) in a specified population of dry eye patients.
Conditions
- Dry Eye
Interventions
- DRUG
-
Systane Free Lubricant Eye Drops
Sponsors & Collaborators
-
Alcon Research
lead INDUSTRY
Principal Investigators
-
Mike Christensen · Alcon Research
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Primary Completion
- 2006-11-30
- Completion
- 2006-11-30
Countries
- United States
Study Locations
More Related Trials
-
Comparative Study of Rohto Dry-Aid® and Systane® Ultra in Patients With Dry Eye
NCT03183089 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and Efficacy Study of Refresh Optive® Gel Drops in Patients With Dry Eye Disease
NCT02280473 ·Status: COMPLETED ·Phase: PHASE3
-
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
NCT01382810 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease
NCT01294384 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of PRO-087 Versus Xyel Ofteno® and Systane Ultra®, on the Ocular Surface of Healthy Subjects
NCT03524157 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye
NCT01657253 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate 0.003% AR-15512 Safety and Drop Attributes
NCT06660290 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of Osmolarity
NCT01386073 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation Following Use of SYSTANE® ULTRA in the Management of Dry Eye
NCT02446015 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
NCT01541891 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Compare a New Eye Drop Formulation With Systane® Gel Drops and Genteal® Lubricant Gel Drops for Moderate to Severe Dry Eye Relief
NCT02455050 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Tolerability and Efficacy of CWT-f-002 Lubricant Eye Drops
NCT05660681 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of the Ophthalmic Solution PRO-087 Versus Systane ® Ultra and Ultra Preservative Free (087LATAMFIV)
NCT03223909 ·Status: COMPLETED ·Phase: PHASE4
-
Systane Clinical Experience Study
NCT00818909 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Systane Free vs. Saline in the Treatment of Dry Eye
NCT00388791 ·Status: COMPLETED ·Phase: PHASE4
-
Tear Film Stability After Instillation of Over-the-Counter (OTC) Artificial Drops
NCT00610480 ·Status: COMPLETED ·Phase: NA
-
Comparison of Efficacy, Safety and Anti-Inflammatory Effect Between Topical 0.05%Cyclosporine A Emulsion and REFRESH® in Patients With Moderate to Severe Dry Eyes
NCT00704275 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety, Efficacy, Tolerability and Pharmacokinetics of AGN-223575 Ophthalmic Suspension in Patients With Dry Eye Disease
NCT02435914 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
NCT01198782 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of SYSTANE® BALANCE on Tear Film Break Up Time in Dry Eye Subjects
NCT01718028 ·Status: COMPLETED ·Phase: NA
-
Tear Lipid Layer Thickness With Emollient Eye Drops
NCT03380624 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Safety and Performance of a Novel Ocular Lubricant in Subjects With Dry Eye Disease
NCT06444516 ·Status: COMPLETED ·Phase: NA
-
Systane Complete Multi-symptom Relief
NCT05056155 ·Status: COMPLETED ·Phase: NA
-
Investigation of Preservative-Free Ophthalmic Solution in Ocular Dryness
NCT05778942 ·Status: COMPLETED